Inhibition of MEK1/2 Signaling Pathway Limits M2 Macrophage Polarization and Interferes in the Dental Socket Repair Process in Mice
Authors:
- Angélica Cristina FonsecaAFAngélica Cristina Fonseca
- Priscila Maria ColavitePCPriscila Maria Colavite
- Michelle de Campos Soriani AzevedoMAMichelle de Campos Soriani Azevedo
- Daniela Carignatto PassadoriDPDaniela Carignatto Passadori
- Jessica Lima MelchiadesJMJessica Lima Melchiades
- Rafael Carneiro OrtizRORafael Carneiro Ortiz
- Camila Oliveira RodiniCRCamila Oliveira Rodini
- Ana Paula Favaro TromboneATAna Paula Favaro Trombone
- Gustavo Pompermaier GarletGGGustavo Pompermaier Garlet
Open Access
Abstract
Dental socket repair theoretically involves a constructive inflammatory immune response, which evolves from an initial M1 prevalence to a subsequent M2 dominance. In this scenario, the MEK1/2 signaling pathway is allegedly involved in M2 polarization. This study aimed to evaluate the impact of MEK1/2 pharmacological inhibition in the local host response and repair outcome. C57Bl/6-WT 8-week-old male mice were submitted to the extraction of the right upper incisor and treated (or not, control group) with MEK1/2 inhibitor PD0325901 (10 mg/kg/24 h/IP, MEK1/2i group) and analyzed at 0, 3, 7, and 14 days using microcomputed tomography, histomorphometry, birefringence, immunohistochemistry, and PCR array analysis. The results demonstrate that MEK1/2 inhibition limits the development of M2 response over time, being associated with lower expression of M2, MSCs, and bone markers, lower levels of growth and osteogenic factors, along with a higher expression of iNOS, IL-1b, IL-6, and TNF-α, as well inflammatory chemokines, indicating a predominantly M1 pro-inflammatory environment. This modulation of local inflammatory immune response is associated with impaired bone formation as demonstrated by microtomographic and histomorphometric data. The results show that MEK1/2 inhibition delays bone repair after tooth extraction, supporting the concept that M2 macrophages are essential elements for host response regulation and proper repair.Keywords
Funding Information
- Sao Paulo Research Foundation (FAPESP) (2015/24637-3, 2018/10177-9)
This publication has 48 references indexed in Scilit:
- PD0325901, an ERK inhibitor, attenuates RANKL‐induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathwaysBioorganic Chemistry, 2022
- FTY720 administration results in a M2 associated immunoregulatory effect that positively influences the outcome of alveolar bone repair outcome in miceBone, 2022
- FGF2 positively regulates osteoclastogenesis via activating the ERK-CREB pathwayArchives of Biochemistry and Biophysics, 2022
- Macrophages in bone fracture healing: Their essential role in endochondral ossificationBone, 2018
- Osteoimmunology in Bone Fracture HealingCurrent Osteoporosis Reports, 2017
- Inflammation, fracture and bone repairBone, 2016
- Macrophages: Their Emerging Roles in BoneJournal of Bone and Mineral Research, 2015
- Recapitulating endochondral ossification: a promising route toin vivobone regenerationJournal of Tissue Engineering and Regenerative Medicine, 2014
- Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib)Bone, 2014
- Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp miceJournal of Bone and Mineral Research, 2011